Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.4 billion focused on developing and commercializing novel therapies for cancer treatment, stands at a ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

India's private wealth management sector is experiencing unprecedented growth, driven by a surge in high-net-worth (HNW) and ultra-high-net-worth (UHNW) individuals. However, this rapid expansion has ...